COGNEX CORP
For the period ended Apr 5, 2026. Filed May 7, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Apr 5, 2026 · Filed May 7, 2026
CGNX$50.80+0.9%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Cash Flows for the
CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
| Three-months Ended | ||
|---|---|---|
| April 5, 2026 | March 30, 2025 | |
| (unaudited) | ||
| Cash flows from operating activities: | ||
| Net income | $51,704 | $23,603 |
| Adjustments to reconcile net income to net cash provided by (used in) operating activities: | ||
| Stock-based compensation expense | 11,933 | 9,939 |
| Depreciation of property, plant, and equipment | 4,703 | 5,306 |
| Amortization of intangible assets | 2,532 | 2,628 |
| Excess and obsolete inventory charges | 364 | 197 |
| Loss on sale of business, net of transaction costs | 1,539 | — |
| Deferred income taxes | 4,740 | (4,689) |
| Other adjustments | (380) | (188) |
| Change in operating assets and liabilities: | ||
| Accounts receivable | (23,711) | (17,183) |
| Unbilled revenue | 593 | 307 |
| Inventories | 8 | 5,474 |
| Prepaid expenses and other current assets | (12,212) | 2,526 |
| Accounts payable | 9,390 | 4,996 |
| Accrued expenses | (13,554) | (6,055) |
| Accrued income taxes | (2,905) | (3,153) |
| Deferred revenue and customer deposits | 12,889 | 14,761 |
| Other | (2,540) | 2,033 |
| Net cash provided by (used in) operating activities | 45,093 | 40,502 |
| Cash flows from investing activities: | ||
| Purchases of investments | (47,013) | (113,297) |
| Maturities and sales of investments | 39,042 | 148,885 |
| Net proceeds from sale of business | 11,519 | — |
| Purchases of property, plant, and equipment, net of proceeds | (2,757) | (2,501) |
| Net cash provided by (used in) investing activities | 791 | 33,087 |
| Cash flows from financing activities: | ||
| Net payments from issuance of common stock under stock plans | 44,290 | (2,587) |
| Repurchase of common stock | (98,995) | (102,233) |
| Payment of dividends | (14,196) | (13,550) |
| Net cash provided by (used in) financing activities | (68,901) | (118,370) |
| Effect of foreign exchange rate changes on cash and cash equivalents | (2,565) | 2,431 |
| Net change in cash and cash equivalents | (25,582) | (42,350) |
| Cash and cash equivalents at beginning of period | 262,925 | 186,094 |
| Cash and cash equivalents at end of period | $237,343 | $143,744 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.